GlassScriptPhysician profile
Ashley Nicole Mitchell
NPI 1003598269
$488.62
in general payments reported to CMS, 2019-2025
13 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $103 · 2024: $268 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $144.53 | 2023-2025 | |
| Novo Nordisk INC | $95.70 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Mylan Specialty L.P. | $56.63 | 2023-2024 | Yupelri |
| Lilly USA, LLC | $28.72 | 2025 | Kisunla |
| Aimmune Therapeutics, INC. | $27.88 | 2024 | |
| Merck Sharp & Dohme LLC | $22.78 | 2024 | Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $18.58 | 2023 | |
| Amgen INC. | $17.06 | 2024 | Otezla, Repatha |
| Phathom Pharmaceuticals, INC. | $16.71 | 2024 | Voquezna |
| Exact Sciences Corporation | $15.89 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $15.64 | 2023 | |
| Sumitomo Pharma America, INC. | $14.76 | 2025 | Gemtesa |
| Glaxosmithkline, LLC. | $13.74 | 2025 | Penmenvy, Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.